Patient Recruitment! 30 patients with mild to moderate Alzheimer's disease can enjoy exclusive medical support

Release time:2025-08-06
views:419
Patient Recruitment

If there is such an elderly person around you, who forgets what he just said as soon as he turns around (。﹏。), calls out familiar family members by the wrong name ( ˇˍˇ ), comes back from the market with an empty basket (;′⌒`), sometimes suddenly loses his temper in an empty room o(︶︿︶)o, and sometimes sits silently by the window for a whole day...

These seemingly minor changes could be early signs of Alzheimers disease! They are quietly stealing the elderlys cognitive and living abilities, and early intervention is the key to delaying the progression of the disease.

If you come across such elderly people, please do tell them - Hainan Chengmei Hospital is currently looking for 30 patients with mild to moderate Alzheimers disease, and will provide professional diagnosis and treatment to help them retain more memories and dignity.

Part.1

Frontier medicine offers support, safeguarding the defense line of memory

Currently, the P-tau217 blood test conducted by Hainan Chengmei Hospital can identify disease risks in advance. The international authoritative journal "Brain" has confirmed the causal relationship between gut microbiota and Alzheimers disease, making "fecal microbiota transplantation (FMT)" a highly promising new treatment direction. These cutting-edge medical advancements are awaiting the attention of those in need.

Part.2

Inclusion criteria for recruitment and enrollment

If you find that the "he" around you meets the following conditions, please be sure to let "him" know this news:

Assessed professionally as being in stage 0-3 of Alzheimers disease.

The result of P-tau217 test (at your own expense) is positive (the test can be conducted at Hainan Chengmei Hospital or Hainan Provincial Cancer Hospital).

No serious underlying diseases and able to cooperate with treatment.

There is a stable caregiver.

Part.3

Exclusive medical support

Eligible patients will receive exclusive medical support from a team led by Professor Dai Wenxin, an expert from the Geriatric Multidisciplinary Diagnosis and Treatment Center of Hainan Chengmei Hospital.

Interpret test reports, assess cognitive function, and analyze the state of intestinal flora;

Enjoy priority access to medical consultation, hospitalization and examination through a green channel.

Receive free scale assessment, intestinal flora testing, and brain and brain-gut axis regulation treatment arranged based on actual conditions.

In addition, after the diagnosis and treatment, the hospital will conduct a follow-up visit for 3 to 6 months to enable "him" and his family to clearly understand the changes in his health.

Dont let the label of "senile" delay the best opportunity.

If you see someone like this "him", please contact the doctors assistant Qiu Wei: 13226895419 (available throughout the working day).

As the first intestinal microecology diagnosis and treatment center in Hainan, the Intestinal Microecology Diagnosis and Treatment Center of Hainan Chengmei Hospital is patient-centered and implements a "multi-disciplinary integration and joint management" diagnosis and treatment model. The center offers novel clinical diagnostic techniques such as intestinal barrier function assessment, fecal microbiota analysis, and intestinal microbiota analysis, as well as new treatment technologies including fecal microbiota transplantation via the lower digestive tract, formula probiotic capsules, and multi-dimensional microecological nutritional intervention. The service scope covers patients with diseases in multiple fields including digestion, cardiovascular, nervous system, tumors, immunity, infectious diseases, and skin diseases.

Expert Introduction

Dai Wenxin, Chief Physician

Executive Director of the Multidisciplinary Geriatric Medicine Center

Professor, Doctoral student, Postdoctoral fellow, Masters supervisor

Medical expertise

I. Diagnosis and treatment of Alzheimers disease and other geriatric diseases;

II. Diagnosis and treatment of multi-disciplinary diseases such as respiratory system, cardiovascular system, nervous system, and geriatric diseases;

III. Genetic diagnosis of tumors and integrated precise treatment including chemotherapy, targeted therapy, immunotherapy, microenvironmental therapy.

IV. Genetic diagnosis and precise treatment of hypertension, hyperlipidemia, hyperuricemia and hyperglycemia;

V. New biomedical technologies such as stem cells and gene programming, as well as new technologies like insulin pumps and diabetes reversal;

VI. High-intensity Focused Ultrasound (HIFU) for the Treatment of Benign and Malignant Tumors

VII. Microbial Therapy of Intestinal Flora for Chronic Diseases and Mental Disorders

VIII. Diagnostic and therapeutic techniques under bronchoscopy, mediastinoscopy, thoracoscopy and other internal medicine endoscopy;

IX. Sleep Medicine

X. Chronic Disease Management.

Editor | Huang Fei